drugset / Trial / NCT02370251

Compassionate Use of Omegaven in Children

NCT02370251

Phase 2/3 Completed 63 enrolled University of Oklahoma OU Medical Center · collab
NaSingle-groupOpen-labelTreatment

Summary

This is a single-assignment study to evaluate whether Omegaven (IV fish oil) is effective at treating liver disease in children on long-term IV nutrition.

Timeline

Start
2015-06
Primary completion
2018-09-27
Completion
2019-09-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Omegaven Other / unclassified 1 g/kg Intravenous